Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Lung cancer"
DOI: 10.1016/j.lungcan.2019.11.010
Abstract: OBJECTIVES The oncogenic MET exon 14 skipping mutation (METex14del) is described to drive 1.3 %-5.7 % of non-small-cell lung cancer (NSCLC) and multiple studies with cMET inhibitors show promising clinical responses. RNA-based analysis seems most… read more here.
Keywords: metex14del; non squamous; dna based; treatment ... See more keywords